Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal

BACKGROUND: Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) against Plasmodium falciparum in highly endemic areas. Ho...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ranjitkar, Samir, Schousboe, Mette L, Thomsen, Thomas Thyge, Adhikari, Madhav, Kapel, Christian MO, Bygbjerg, Ib C, Alifrangis, Michael
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3080351/
https://ncbi.nlm.nih.gov/pubmed/21457533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-10-75
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi